DK420487D0 - Nucleinsyresekvens, der koder for en carcinoembryonisk antigenpeptid-sekvens - Google Patents

Nucleinsyresekvens, der koder for en carcinoembryonisk antigenpeptid-sekvens

Info

Publication number
DK420487D0
DK420487D0 DK420487A DK420487A DK420487D0 DK 420487 D0 DK420487 D0 DK 420487D0 DK 420487 A DK420487 A DK 420487A DK 420487 A DK420487 A DK 420487A DK 420487 D0 DK420487 D0 DK 420487D0
Authority
DK
Denmark
Prior art keywords
nucleic acid
carcinoembryonic antigen
antigen peptide
cea
acid sequence
Prior art date
Application number
DK420487A
Other languages
English (en)
Other versions
DK173134B1 (da
DK420487A (da
Inventor
Thomas R Barnett
James J Elting
Michael E Kamarck
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of DK420487D0 publication Critical patent/DK420487D0/da
Publication of DK420487A publication Critical patent/DK420487A/da
Application granted granted Critical
Publication of DK173134B1 publication Critical patent/DK173134B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK198704204A 1986-08-13 1987-08-12 Isoleret nucleinsyre, der koder for et polypeptid hørende til CEA-genfamilien, replikerbart rekombinant klonings-vehikel me DK173134B1 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89636186A 1986-08-13 1986-08-13
US1668387A 1987-02-19 1987-02-19
US6003187A 1987-06-19 1987-06-19

Publications (3)

Publication Number Publication Date
DK420487D0 true DK420487D0 (da) 1987-08-12
DK420487A DK420487A (da) 1988-02-14
DK173134B1 DK173134B1 (da) 2000-01-31

Family

ID=27360631

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198704204A DK173134B1 (da) 1986-08-13 1987-08-12 Isoleret nucleinsyre, der koder for et polypeptid hørende til CEA-genfamilien, replikerbart rekombinant klonings-vehikel me

Country Status (12)

Country Link
EP (1) EP0263933B1 (da)
JP (2) JP3253609B2 (da)
AT (1) ATE96168T1 (da)
AU (1) AU598573B2 (da)
DE (1) DE3787864T2 (da)
DK (1) DK173134B1 (da)
ES (1) ES2059330T3 (da)
FI (1) FI873478L (da)
IE (1) IE60279B1 (da)
IL (1) IL83484A (da)
NZ (1) NZ221385A (da)
ZA (1) ZA875951B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122599A (en) * 1986-08-13 1992-06-16 Molecular Diagnostics, Inc. CDNAS coding for members of the carcinoembryonic antigen family
JP2607492B2 (ja) * 1987-01-14 1997-05-07 サントリー株式会社 ヒト癌胎児性抗原
US4908417A (en) * 1988-05-17 1990-03-13 Sumitomo Chemical Company, Limited Thermosetting resin composition
JPH02107189A (ja) * 1988-05-25 1990-04-19 City Of Hope 癌胎児抗原フラグメント
EP0346702A3 (en) * 1988-06-16 1991-08-28 Miles Inc. Transfectant cell lines which express isolated genes of the carcinoembryonic antigen family
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
DK0584266T3 (da) * 1991-05-06 2003-12-29 Us Gov Health & Human Serv Rekombinant virus udtrykkende carcinoembryonalt antigen og fremgangsmåder til anvendelse heraf
CA2116640A1 (en) * 1993-03-25 1994-09-26 Alexey Terskikh Carcinoembryonic antigen derivatives
US6001349A (en) 1995-02-22 1999-12-14 Therion Biologics Corporation Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
CN100523216C (zh) * 2001-03-02 2009-08-05 匹兹堡大学 Pcr方法
US8119352B2 (en) 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
AU2009223727B2 (en) 2008-03-14 2014-09-11 Sanofi Pasteur Biologics, Llc Replication-defective flavivirus vaccines and vaccine vectors
TWI732259B (zh) 2010-12-16 2021-07-01 美商建南德克公司 關於th2抑制作用之診斷及治療
WO2014140938A2 (en) 2013-03-14 2014-09-18 Centre Hospitalier Universitaire Vaudois Immunological methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4228236A (en) * 1978-05-15 1980-10-14 Northwestern University Process of producing carcinoembryonic antigen
JP2507982B2 (ja) * 1984-04-10 1996-06-19 武田薬品工業株式会社 ヒト癌胎児性抗原反応性モノクロ―ナル抗体の製造法

Also Published As

Publication number Publication date
DE3787864T2 (de) 1994-02-10
EP0263933B1 (en) 1993-10-20
IE872161L (en) 1988-02-13
NZ221385A (en) 1991-06-25
DK173134B1 (da) 2000-01-31
IL83484A (en) 1993-01-31
FI873478A0 (fi) 1987-08-11
DE3787864D1 (de) 1993-11-25
AU7686887A (en) 1988-03-24
EP0263933A1 (en) 1988-04-20
AU598573B2 (en) 1990-06-28
JPH09136900A (ja) 1997-05-27
FI873478A7 (fi) 1988-02-14
JPS63119681A (ja) 1988-05-24
DK420487A (da) 1988-02-14
ATE96168T1 (de) 1993-11-15
JP3253609B2 (ja) 2002-02-04
IL83484A0 (en) 1988-01-31
ZA875951B (en) 1988-02-19
FI873478L (fi) 1988-02-14
ES2059330T3 (es) 1994-11-16
IE60279B1 (en) 1994-06-29

Similar Documents

Publication Publication Date Title
EP0346710A3 (en) Cdnas coding for members of the carcinoembryonic antigen family
DK420487D0 (da) Nucleinsyresekvens, der koder for en carcinoembryonisk antigenpeptid-sekvens
NL300197I1 (da)
DK108589A (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen samt dna-sekvenser, der koder for saadanne antistoffer
DK73483A (da) Dna-sekvenser, rekombinant-dna-molekyler samt fremgangsmaader til fremstilling af human-immune interferonlignende polypeptider
AU5909386A (en) Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
DE68905633D1 (de) Markierer der t-zelle aktivierung.
DK108189A (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen og metal-chelater samt dna-sekvenser, der koder for saadanne antistoffer
NO932890L (no) Strukturelt gen for pnumokokkisk protein
DE3585790D1 (de) Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen.
EP0149548A3 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
ES8800266A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
ATE157545T1 (de) Antigene proteine und diese enthaltende impfstoffe zur verhütung von kokzidiose
GB8501473D0 (en) Cloned dna sequences
NZ211357A (en) Recombinant dna and antigenic protein coded for
EP0152612A3 (en) Determination of fibrin with fibrin-specific antibodies
EP0293079A3 (en) Chlamydia vaccine
DE3686452D1 (de) Aktiviertes bacillus thuringiensis-delta-endotoxin, hergestellt von einem manipulierten hybrid-gen.
EP0293827A3 (en) Assay for leishmaniasis
DK447083A (da) Dna, som koder for humant interferon-gamma, rekombinant-dna indeholdende denne dna, mikroorganisme indeholdende rekombinant-dna'en og fremgangsmaade til fremstilling af humant interferon-gamma-polypeptid
DK130290D0 (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
GR3015074T3 (en) Recombinant treponema hyodysenteriae antigen and uses therefor.
FI870501A0 (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired